Hilo Yen
Impact in
- Endocrinology top 2%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Escherichia coli research studies 11
- Vibrio bacteria research studies 2
-
- Viral gastroenteritis research and epidemiology 5
- Co-authors
- Toru Tobe (7 shared papers)Nakaba Sugimoto (2 shared papers)Tetsuya Hayashi (1 shared paper)Atsushi Iguchi (1 shared paper)Tadasuke Ooka (1 shared paper)Daijiro Sugiyama (3 shared papers)Toru Nakano (3 shared papers)Kenji Kitajima (3 shared papers)
- Journals
- Cellular Microbiology (2 papers)PLoS Pathogens (2 papers)Blood (2 papers)BMC Microbiology (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)
- Partner nations
- JapanSwitzerlandSouth Korea
In The Last Decade
Hilo Yen
14 papers receiving 472 citations
Peers
Comparison fields: 5 of 57
- Endocrinology 195
- Molecular Medicine 47
- Immunology 122
- Infectious Diseases 100
- Microbiology 31
Countries citing papers authored by Hilo Yen
This map shows the geographic impact of Hilo Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilo Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilo Yen more than expected).
Fields of papers citing papers by Hilo Yen
This network shows the impact of papers produced by Hilo Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilo Yen. The network helps show where Hilo Yen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hilo Yen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 129 | |
| 2 | 2015 | 82 | |
| 3 | 2005 | 60 | |
| 4 | 2014 | 42 | |
| 5 | 2007 | 28 | |
| 6 | 2017 | 27 | |
| 7 | 2006 | 27 | |
| 8 | 2016 | 24 | |
| 9 | 2014 | 23 | |
| 10 | 2014 | 15 | |
| 11 | 2017 | 13 | |
| 12 | 2020 | 3 | |
| 13 | 2022 | 1 | |
| 14 | 2023 | 1 |
About Hilo Yen
Hilo Yen is a scholar working on Endocrinology, Infectious Diseases, Molecular Biology, Genetics and Immunology, having authored 14 papers that have together received 475 indexed citations. Recurring topics across this work include Escherichia coli research studies (11 papers), Viral gastroenteritis research and epidemiology (5 papers), Bacterial Genetics and Biotechnology (4 papers), Epigenetics and DNA Methylation (3 papers), Immune Response and Inflammation (3 papers), Vibrio bacteria research studies (2 papers), Acute Myeloid Leukemia Research (1 paper) and Bacterial Infections and Vaccines (1 paper). The work is most often cited by research in Endocrinology (195 citations), Molecular Medicine (47 citations), Immunology (122 citations), Infectious Diseases (100 citations) and Microbiology (31 citations). Hilo Yen has collaborated with scholars based in Japan, Switzerland and South Korea. Frequent co-authors include Toru Tobe, Nakaba Sugimoto, Tetsuya Hayashi, Atsushi Iguchi, Tadasuke Ooka, Daijiro Sugiyama, Toru Nakano, Kenji Kitajima, Toru Tobe and Jie Zheng. Their work appears in journals such as Cellular Microbiology, PLoS Pathogens, Blood, BMC Microbiology and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.